JW PharmaceuticalJW중외제약
001060 · KOSPI · ₩001060 · JW중외제약
₩23,150▼ ₩50 (0.22%)End-of-day · Oct 29, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 47.3% | 46.3% | 45.0% | 44.8% | 42.1% | 38.6% |
| Operating margin | 13.9% | 12.2% | 11.5% | 13.4% | 9.2% | 5.1% |
| Net margin | 12.3% | 7.9% | 9.0% | 4.9% | 4.7% | −0.2% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +5.9% | +7.8% | −3.9% | +9.4% | +12.8% | — |
| Operating income growth | +21.1% | +14.5% | −17.8% | +59.3% | +101.8% | — |
| Net income growth | +64.7% | −5.4% | +75.8% | +16.0% | +3,395.1% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 26.0% | 17.6% | 21.9% | 15.1% | 15.4% | −0.5% |
| Return on assets | 14.4% | 10.2% | 10.4% | 6.0% | 4.7% | −0.2% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 61.0% | 63.9% | 83.5% | 143.0% | 178.2% | 235.8% |
| Net debt to equity | −1.2% | −4.4% | 10.7% | −12.4% | — | — |
| Current ratio | 156.1% | 141.8% | 146.9% | 131.8% | 111.9% | 129.6% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: JW Pharmaceutical / JW중외제약 / 001060 / KRX:001060
Source: KRX statistical information